Abstract
In autoimmune disease, multifaceted approaches are being explored to tailor a particular treatment that targets a specific cell at the appropriate disease stage. The key roles of B lymphocytes have enabled them to enter the clinical arena. In turn, clinical trials have suggested several leads for future research.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
O'Neill, S.K. et al. Proc. Natl. Acad. Sci. USA 106, 6262–6267 (2009).
Goodnow, C.C., Vinuesa, C.G., Randall, K.L., Mackay, F. & Brink, R. Nat. Immunol. 11, 681–688 (2010).
Aiba, Y. et al. Proc. Natl. Acad. Sci. USA 107, 12192–12197 (2010).
Schwickert, T., Alabyev, B., Manser, T. & Nussenzweig, M.C. J. Exp. Med. 206, 2907–2914 (2009).
Linterman, M.A. et al. J. Exp. Med. 206, 561–576 (2009).
Good-Jacobson, K.L. et al. Nat. Immunol. 11, 535–542 (2010).
Keenan, R. et al. Science 321, 696–699 (2008).
Minegishi, Y. & Conley, M. Immunity 14, 631–641 (2001).
Hauser, S. N. Engl. J. Med. 359, 1838–1841 (2008).
Pollinger, B. et al. J. Exp. Med. 206, 1303–1316 (2009).
Zouali, M. & Sarmay, G. Arthritis Rheum. 50, 2730–2741 (2004).
Tchilian, E.Z. & Beverley, P.C. Trends Immunol. 27, 146–153 (2006).
Hermiston, M.L., Tan, A.L., Gupta, V.A., Majeti, R. & Weiss, A. Immunity 23, 635–647 (2005).
Pescovitz, M. et al. N. Engl. J. Med. 361, 2143–2152 (2009).
Acknowledgements
We thank colleagues for allowing citation of unpublished data and apologize for the omission of other data because of space limitations.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hikada, M., Zouali, M. Multistoried roles for B lymphocytes in autoimmunity. Nat Immunol 11, 1065–1068 (2010). https://doi.org/10.1038/ni1210-1065
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1210-1065
This article is cited by
-
Belimumab Therapy in Systemic Lupus Erythematosus
BioDrugs (2013)